Aguilar Laura K. 4
4 · Candel Therapeutics, Inc. · Filed Aug 2, 2021
Insider Transaction Report
Form 4
Aguilar Laura K.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-07-29−137,881→ 0 total→ Common Stock (56,096 underlying) - Conversion
Common Stock
2021-07-29+56,096→ 931,039 total
Holdings
- 2,013,100(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
- [F2]Includes 32,399 shares of common stock held jointly with spouse.
- [F3]Shares held by the Laura K. Aguilar 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.